MAP2K7 and melanoma: In the study of Young et al. [80], IL-8 that stimulated the survival of melanoma cells in the presence of BRAF and MEK inhibitors, was released by fibroblasts located in inflammatory niche of the tumor, whereas our study suggests that autocrine signaling is also possible.